α‐Aminosilanes are an important class of organic compounds that show biological activity. In this communication, a new approach to α‐aminosilanes that utilizes photoredox catalysis to enable three‐component coupling of organo(tristrimethylsily...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=O107919395
2021년
eng
1433-7851
1521-3773
SCI;SCIE;SCOPUS
학술저널
Angewandte Chemie international edition
23335-23341 [※수록면이 p5 이하이면, Review, Columns, Editor's Note, Abstract 등일 경우가 있습니다.]
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
α‐Aminosilanes are an important class of organic compounds that show biological activity. In this communication, a new approach to α‐aminosilanes that utilizes photoredox catalysis to enable three‐component coupling of organo(tristrimethylsily...
α‐Aminosilanes are an important class of organic compounds that show biological activity. In this communication, a new approach to α‐aminosilanes that utilizes photoredox catalysis to enable three‐component coupling of organo(tristrimethylsilyl)silanes with feedstock alkylamines and aldehydes is presented. A wide range of highly functionalized α‐aminosilanes can be obtained in good yields under mild conditions. Both primary amines and secondary amines are compatible with this transformation. Moreover, optically pure α‐aminosilanes are accessible by using chiral amines. Mechanistic studies indicate that reactions proceed through radical/radical cross‐coupling of silyl radicals with α‐amino alkyl radicals.
Direct cross‐coupling of organo(tristrimethylsilyl)silanes with alkylamine and aldehyde feedstocks has been achieved. A wide range of highly functionalized α‐aminosilanes can be obtained with generally good yields and optically pure α‐aminosilanes are accessible with excellent stereocontrol. This method provides a novel disconnection strategy for the synthesis of a diverse range of α‐aminosilanes.
Exploring Ultrafast Photoswitching Pathways in RbMnFe Prussian Blue Analogue
Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer